Company profile: BioVentrix
1.1 - Company Overview
Company description
- Provider of medical devices and clinical programs for congestive heart failure: the Revivent TC TransCatheter Ventricular Enhancement System to reshape the left ventricle and improve function by excluding scarred tissue using micro-anchor implants; the ALIVE clinical study for LV scarring; NYHA III–IV patient identification criteria and training; and an educational resource library.
Products and services
- Revivent TC TransCatheter Ventricular Enhancement System: Engineered transcatheter system that reshapes the left ventricle to improve function by employing micro-anchor implants to exclude scarred myocardium
- Micro-Anchor Implant: Implantable component of the Revivent TC System that excludes scarred myocardial tissue and restores ventricular shape for heart failure treatment
- ALIVE Clinical Study: Clinical investigation treating heart failure with left ventricular scarring using the Revivent TC System to reshape the left ventricle
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioVentrix
Excision Medical
HQ: United States
Website
- Description: Provider of tools for TAVR procedures focused on safe, reliable leaflet modification and excision, device steering, and temporary hemodynamic support. Offerings include the Leaflet Excision System to target and excise aortic valve leaflets and mitigate risks during redo TAVR, Stýri steering catheters, Viking RF Excision Catheter, and HemoShield temporary valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Excision Medical company profile →
CardioFocus
HQ: United States
Website
- Description: Provider of cardiac ablation technologies, including the HeartLight X3 laser balloon catheter for pulmonary vein isolation in atrial fibrillation with direct visualization, titratable laser energy, and compliant balloon technology, and the CENTAURI system leveraging Pulsed Electric Field for intracardiac ablation, compatible with existing mapping systems and focal ablation catheters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardioFocus company profile →
HighLife Medical
HQ: France
Website
- Description: Provider of transcatheter mitral valve replacement solutions for patients with mitral valve regurgitation. Offers the HighLife TSMVR Solution, a system designed for moderate to severe mitral regurgitation patients at high surgical risk; technology is currently in clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighLife Medical company profile →
Relypsa
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of non-absorbed polymeric drugs for cardiovascular and renal diseases, specializing in iron deficiency, nephrology, and cardio-renal therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Relypsa company profile →
Calon Cardio
HQ: United Kingdom
Website
- Description: Provider of implantable micro blood pumps for the treatment of chronic heart failure. Its Calon MiniVAD is a miniature implantable pump placed in the left ventricle to help provide blood supply to the body, alleviate debilitating symptoms, improve blood flow, and reduce complications such as blood damage and thrombus formation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calon Cardio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioVentrix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioVentrix
2.2 - Growth funds investing in similar companies to BioVentrix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioVentrix
4.2 - Public trading comparable groups for BioVentrix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →